NHS South West London does not support the routine NHS prescribing of certain medicines, in line with NHS England’s national consultation and published guidance (2017). These medicines are items that are either:
- of low clinical effectiveness i.e. where there is a lack of robust evidence of clinical effectiveness or have significant safety concerns
- no longer licensed in the UK
- are clinically effective but are not cost effective for the NHS
- are clinically effective but there are more cost effective products available
- are available over-the-counter and inexpensive to purchase
The NHS in SW London is currently facing a significant financial challenge and must focus its resources on the areas of greatest need. We need to prioritise and make tough decisions to secure the future of local health services for everyone in SW London.
Please note that these position statements are subject to approval by the individual Clinical Commissioning Groups – see footers of the individual position statements for full information.
Prescriber: professional and contractual context
During discussions with the patient, when considering what treatment and ongoing monitoring is required, clinicians are asked to be mindful of the following:
- that within their Primary Medical Services contract with NHS England, GPs have a contractual obligation relating to patients with chronic disease to make available such treatment (including any prescription deemed to be appropriate after discussion with the patient) as is necessary and appropriate, and to provide advice in connection with the patient’s health, including relevant health promotion advice
- that reference to local prescribing guidelines is good professional practice
- that consideration of GMC professional obligations to use NHS resources wisely is good professional practice
For the Position Statement for prescribing preparations available to buy over the counter (OTC) for self-care and related documents, please click here.